From A4M Partner Pharmacy Podcast Network‘s Magazine
By Todd S. Eury
The controversy surrounding CBD’s use as a treatment option for pain and other medical conditions hasn’t stopped it from skyrocketing to fame.
Today, CBD is one of the fastest growing industries globally with a projected market value of $23.7 billion by 2023. Last year, 14% of Americans admitted to using CBD, while 64% of seniors who tried CBD said it helped somehow. Let’s take a closer look at what CBD is and how it works:
First identified in the early 1990s, the endocannabinoid system (ECS) has emerged as an important neuromodulatory system over recent years. The complex cell-signaling system regulates and controls many bodily functions, active in the body without the use of cannabis. A growing understanding of the ECS and the role it plays in a wide-range of biological pathways has placed it at the center of increasing international research and drug development efforts. As a result, the burgeoning field of ECS-targeted therapeutics and their approved applications in clinical practice are likely to expand exponentially in the near future.
October 12th marks World Arthritis Awareness Day, which is a global awareness-raising effort aimed to educate, support, and build a sense of community among arthritis patients. With an emphasis on early diagnosis and treatment, rheumatoid and musculoskeletal disease organizations work to foster a growing understanding of one of the world’s most prevalent conditions. As one of the leading causes of disability in the United States, arthritis affects the functioning and quality of life of more than 50 million Americans. Treatment options range from hydrotherapy to nonsteroidal anti-inflammatory drugs, however, increased attention is being directed toward the healing potential of cannabidiol (CBD).
